FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387466587> ?p ?o ?g. }

• W4387466587 endingPage "214" @default.
• W4387466587 startingPage "207" @default.
• W4387466587 abstract "To present an update of the recommendations of the Brazilian College of Radiology and Diagnostic Imaging, the Brazilian Society of Mastology, and the Brazilian Federation of Gynecology and Obstetrics Associations for breast cancer screening in Brazil.Scientific evidence published between January 2012 and July 2022 was gathered from the following databases: Medline (PubMed); Excerpta Medica (Embase); Cochrane Library; Ebsco; Cumulative Index to Nursing and Allied Health Literature (Cinahl); and Latin-American and Caribbean Health Sciences Literature (Lilacs). Recommendations were based on that evidence and were arrived at by consensus of a joint committee of experts from the three entities.Recommendations: Annual mammographic screening is recommended for women between 40 and 74 years of age. For women at or above the age of 75, screening should be reserved for those with a life expectancy greater than seven years. Women at higher than average risk are considered by category: those with dense breasts; those with a personal history of atypical lobular hyperplasia, classical lobular carcinoma in situ, or atypical ductal hyperplasia; those previously treated for breast cancer; those having undergone thoracic radiotherapy before age 30; and those with a relevant genetic mutation or a strong family history. The benefits of complementary screening are also addressed according to the subcategories above. The use of tomosynthesis, which is an evolved form of mammography, should be considered in screening, whenever accessible and available.Apresentar a atualização das recomendações do Colégio Brasileiro de Radiologia e Diagnóstico por Imagem, da Sociedade Brasileira de Mastologia e da Federação Brasileira das Associações de Ginecologia e Obstetrícia para o rastreamento do câncer de mama no Brasil.Foram feitas buscas das evidências científicas publicadas nas bases Medline (PubMed), Excerpta Medica (Embase), Cochrane Library, Ebsco, Cinahl e Lilacs, entre janeiro de 2012 e julho de 2022. As recomendações foram baseadas nessas evidências, mediante consenso da comissão de especialistas das três entidades.Recomendações: O rastreamento mamográfico anual é recomendado para as mulheres de risco habitual entre 40 e 74 anos. Acima de 75 anos deve ser reservado para as que tenham expectativa de vida maior que sete anos. Mulheres com risco maior que o habitual, entre elas as com mamas densas, com história pessoal de hiperplasia lobular atípica, carcinoma lobular in situ clássico, hiperplasia ductal atípica, tratamento de câncer de mama ou de irradiação no tórax antes dos 30 anos, ou ainda portadoras de mutação genética ou com forte história familiar, se beneficiam do rastreamento complementar, sendo consideradas de forma individualizada. A tomossíntese é uma evolução da mamografia e deve ser considerada no rastreamento, sempre que acessível e disponível." @default.
• W4387466587 created "2023-10-10" @default.
• W4387466587 creator A5001117733 @default.
• W4387466587 creator A5005043985 @default.
• W4387466587 creator A5007153601 @default.
• W4387466587 creator A5010233186 @default.
• W4387466587 creator A5014109737 @default.
• W4387466587 creator A5021422049 @default.
• W4387466587 creator A5022082409 @default.
• W4387466587 creator A5030600770 @default.
• W4387466587 creator A5037858494 @default.
• W4387466587 creator A5046370160 @default.
• W4387466587 creator A5048143084 @default.
• W4387466587 creator A5049232591 @default.
• W4387466587 creator A5050598582 @default.
• W4387466587 creator A5050833993 @default.
• W4387466587 creator A5056252922 @default.
• W4387466587 creator A5058113788 @default.
• W4387466587 creator A5062865498 @default.
• W4387466587 creator A5065852337 @default.
• W4387466587 creator A5067399777 @default.
• W4387466587 date "2023-01-01" @default.
• W4387466587 modified "2023-10-16" @default.
• W4387466587 title "Recommendations for breast cancer screening in Brazil, from the Brazilian College of Radiology and Diagnostic Imaging, the Brazilian Society of Mastology, and the Brazilian Federation of Gynecology and Obstetrics Associations" @default.
• W4387466587 cites W1537982109 @default.
• W4387466587 cites W1798588933 @default.
• W4387466587 cites W1858836658 @default.
• W4387466587 cites W1965217852 @default.
• W4387466587 cites W1988911044 @default.
• W4387466587 cites W1990659977 @default.
• W4387466587 cites W2002119787 @default.
• W4387466587 cites W2038751842 @default.
• W4387466587 cites W2081202195 @default.
• W4387466587 cites W2097361420 @default.
• W4387466587 cites W2112090688 @default.
• W4387466587 cites W2124653673 @default.
• W4387466587 cites W2125401785 @default.
• W4387466587 cites W2137040237 @default.
• W4387466587 cites W2147589959 @default.
• W4387466587 cites W2149291062 @default.
• W4387466587 cites W2153119695 @default.
• W4387466587 cites W2155329254 @default.
• W4387466587 cites W2156795189 @default.
• W4387466587 cites W2157927416 @default.
• W4387466587 cites W2161484565 @default.
• W4387466587 cites W2172296348 @default.
• W4387466587 cites W2237958539 @default.
• W4387466587 cites W2291904792 @default.
• W4387466587 cites W2299537488 @default.
• W4387466587 cites W2514810616 @default.
• W4387466587 cites W2547430480 @default.
• W4387466587 cites W2590162823 @default.
• W4387466587 cites W2616240394 @default.
• W4387466587 cites W2644595080 @default.
• W4387466587 cites W2756074972 @default.
• W4387466587 cites W2798167579 @default.
• W4387466587 cites W2801665024 @default.
• W4387466587 cites W2912529815 @default.
• W4387466587 cites W2944733751 @default.
• W4387466587 cites W2948528372 @default.
• W4387466587 cites W2949999402 @default.
• W4387466587 cites W2955916983 @default.
• W4387466587 cites W2981022478 @default.
• W4387466587 cites W2987180518 @default.
• W4387466587 cites W2991330623 @default.
• W4387466587 cites W2994766824 @default.
• W4387466587 cites W2999433859 @default.
• W4387466587 cites W3031321793 @default.
• W4387466587 cites W3045607691 @default.
• W4387466587 cites W3101176916 @default.
• W4387466587 cites W3116889151 @default.
• W4387466587 cites W3131669113 @default.
• W4387466587 cites W3135949681 @default.
• W4387466587 cites W3170769496 @default.
• W4387466587 cites W3193648988 @default.
• W4387466587 cites W3209249397 @default.
• W4387466587 cites W4210535138 @default.
• W4387466587 cites W4220900070 @default.
• W4387466587 cites W4225388971 @default.
• W4387466587 cites W4246771217 @default.
• W4387466587 cites W4310706562 @default.
• W4387466587 cites W4319311958 @default.
• W4387466587 cites W4324130416 @default.
• W4387466587 cites W4365444023 @default.
• W4387466587 cites W4372232620 @default.
• W4387466587 cites W786176465 @default.
• W4387466587 doi "https://doi.org/10.1590/0100-3984.2023.0064-en" @default.
• W4387466587 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37829583" @default.
• W4387466587 hasPublicationYear "2023" @default.
• W4387466587 type Work @default.
• W4387466587 citedByCount "0" @default.
• W4387466587 crossrefType "journal-article" @default.
• W4387466587 hasAuthorship W4387466587A5001117733 @default.
• W4387466587 hasAuthorship W4387466587A5005043985 @default.
• W4387466587 hasAuthorship W4387466587A5007153601 @default.
• W4387466587 hasAuthorship W4387466587A5010233186 @default.
• W4387466587 hasAuthorship W4387466587A5014109737 @default.
• W4387466587 hasAuthorship W4387466587A5021422049 @default.

• next